Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Trichomonas vaginalis | Clan CA, family C1, cathepsin B-like cysteine peptidase | 0.3679 | 0.6142 | 0.5 |
Schistosoma mansoni | methyl-cpg binding protein mbd | 0.0113 | 0.002 | 0.002 |
Loa Loa (eye worm) | PHD-finger family protein | 0.0188 | 0.0149 | 0.2111 |
Loa Loa (eye worm) | bromodomain containing protein | 0.0124 | 0.0038 | 0.0299 |
Echinococcus multilocularis | bromodomain adjacent to zinc finger domain | 0.0238 | 0.0235 | 0.4326 |
Loa Loa (eye worm) | hypothetical protein | 0.0254 | 0.0262 | 0.3972 |
Brugia malayi | Bromodomain containing protein | 0.0504 | 0.069 | 1 |
Echinococcus granulosus | bromodomain adjacent to zinc finger domain | 0.0238 | 0.0235 | 0.4326 |
Schistosoma mansoni | histone-lysine n-methyltransferase setb1 | 0.0113 | 0.002 | 0.002 |
Loa Loa (eye worm) | hypothetical protein | 0.0277 | 0.0301 | 0.4598 |
Echinococcus granulosus | zinc finger protein | 0.0136 | 0.006 | 0.0806 |
Schistosoma mansoni | histone-lysine n-methyltransferase setb1 | 0.0113 | 0.002 | 0.002 |
Schistosoma mansoni | bromodomain containing protein | 0.0426 | 0.0557 | 0.0557 |
Echinococcus multilocularis | fetal alzheimer antigen, falz | 0.0149 | 0.0082 | 0.1258 |
Plasmodium falciparum | dipeptidyl aminopeptidase 2 | 0.5926 | 1 | 1 |
Schistosoma mansoni | zinc finger protein | 0.0136 | 0.006 | 0.006 |
Schistosoma mansoni | hypothetical protein | 0.0137 | 0.0061 | 0.0061 |
Trypanosoma cruzi | ISWI complex protein | 0.0101 | 0 | 0.5 |
Leishmania major | hypothetical protein, conserved | 0.0101 | 0 | 0.5 |
Echinococcus multilocularis | zinc finger protein | 0.0136 | 0.006 | 0.0806 |
Schistosoma mansoni | acetyl-CoA C-acetyltransferase | 0.0149 | 0.0082 | 0.0082 |
Trypanosoma cruzi | ISWI complex protein | 0.0101 | 0 | 0.5 |
Schistosoma mansoni | dipeptidyl-peptidase I (C01 family) | 0.5926 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0289 | 0.0322 | 0.4954 |
Echinococcus multilocularis | bromodomain adjacent to zinc finger domain | 0.0402 | 0.0516 | 1 |
Echinococcus granulosus | bromodomain adjacent to zinc finger domain | 0.0402 | 0.0516 | 1 |
Trypanosoma brucei | ISWI complex protein | 0.0101 | 0 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0469 | 0.063 | 1 |
Schistosoma mansoni | methyl-cpg binding protein mbd | 0.0113 | 0.002 | 0.002 |
Plasmodium falciparum | dipeptidyl aminopeptidase 1 | 0.5926 | 1 | 1 |
Plasmodium vivax | dipeptidyl aminopeptidase 2, putative | 0.5926 | 1 | 1 |
Brugia malayi | Bromodomain containing protein | 0.026 | 0.0273 | 0.2673 |
Plasmodium vivax | dipeptidyl aminopeptidase 1, putative | 0.5926 | 1 | 1 |
Toxoplasma gondii | preprocathepsin c precursor, putative | 0.5926 | 1 | 1 |
Toxoplasma gondii | cathepsin CPC1 | 0.5926 | 1 | 1 |
Echinococcus granulosus | fetal alzheimer antigen falz | 0.0149 | 0.0082 | 0.1258 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IC50 (binding) | = 4.6 | Inhibition of thymidylate synthase | ChEMBL. | 20153089 |
IC50 (functional) | = 1.2 uM | Concentration required to inhibit 50 percent growth of L1210 mouse leukemia cells | ChEMBL. | 2231606 |
IC50 (functional) | = 1.2 uM | Concentration required to inhibit 50 percent growth of L1210 mouse leukemia cells | ChEMBL. | 2231606 |
IC50 (binding) | = 25 uM | Concentration required for in vitro inhibition of thymidylate synthase | ChEMBL. | 2231606 |
IC50 (binding) | = 25 uM | Concentration required for in vitro inhibition of thymidylate synthase | ChEMBL. | 2231606 |
Species name | Source | Reference | Is orphan |
---|---|---|---|
Mus musculus | ChEMBL23 | 2231606 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
2 literature references were collected for this gene.